GR82580B - Retarding oral acetylsalicyl acid formulations - Google Patents

Retarding oral acetylsalicyl acid formulations

Info

Publication number
GR82580B
GR82580B GR82580A GR840182580A GR82580B GR 82580 B GR82580 B GR 82580B GR 82580 A GR82580 A GR 82580A GR 840182580 A GR840182580 A GR 840182580A GR 82580 B GR82580 B GR 82580B
Authority
GR
Greece
Prior art keywords
retarding
oral
acid formulations
acetylsalicyl
acetylsalicyl acid
Prior art date
Application number
GR82580A
Other languages
English (en)
Inventor
Bernard Dr Streuff
Johann Prof Dr Putter
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR82580B publication Critical patent/GR82580B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR82580A 1983-12-23 1984-12-21 Retarding oral acetylsalicyl acid formulations GR82580B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3346571A DE3346571A1 (de) 1983-12-23 1983-12-23 Oral retardierte acetylsalicylsaeureformulierungen

Publications (1)

Publication Number Publication Date
GR82580B true GR82580B (en) 1985-04-23

Family

ID=6217790

Family Applications (1)

Application Number Title Priority Date Filing Date
GR82580A GR82580B (en) 1983-12-23 1984-12-21 Retarding oral acetylsalicyl acid formulations

Country Status (12)

Country Link
US (1) US4601895A (el)
EP (1) EP0146863A3 (el)
JP (1) JPS60152411A (el)
KR (1) KR850004393A (el)
AU (1) AU3658984A (el)
DE (1) DE3346571A1 (el)
ES (1) ES8605676A1 (el)
GR (1) GR82580B (el)
HU (1) HU191738B (el)
IL (1) IL73879A0 (el)
PT (1) PT79701A (el)
ZA (1) ZA8410045B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615027A (ja) * 1984-06-18 1986-01-10 Sadahiro Nakano 徐放性固形製剤
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
US4855139A (en) * 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
JPH08512291A (ja) * 1993-04-23 1996-12-24 バイオ−テクノロジー・ジェネラル・コーポレーション 血栓溶解の増強方法
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics
US20080132456A1 (en) * 2004-12-09 2008-06-05 Ragnar Ek Pharmaceutical Formulation Comprising Low Crystallinity Cellulose

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE737909C (de) * 1940-11-19 1943-07-29 Apothekerschaft Deutsche Verfahren zur Beseitigung des Wasseranziehungsvermoegens und zur geschmacklichen Verbesserung arzneilich verwendbarer Stoffe
US3034911A (en) * 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
NL271458A (el) * 1960-11-17
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4328217A (en) * 1972-12-29 1982-05-04 Mead Johnson & Company Bran tablet composition and process
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4086335A (en) * 1975-10-29 1978-04-25 Bruscato Frank N Pharmaceutical tablets containing chitin as a disintegrant
DE2708513C3 (de) * 1977-02-26 1981-01-08 C.H. Boehringer Sohn, 6507 Ingelheim Wasserunlösliche, physiologisch unbedenkliche Masse, Verfahren zu ihrer Herstellung und ihre Verwendung
US4198507A (en) * 1978-11-13 1980-04-15 Hoffmann-La Roche Inc. Theophylline magnesium salicylate
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
US4401665A (en) * 1981-04-14 1983-08-30 Bristol-Myers Company Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4390545A (en) * 1981-11-19 1983-06-28 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4525345A (en) * 1981-12-24 1985-06-25 Verex Laboratories, Inc. Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules

Also Published As

Publication number Publication date
JPS60152411A (ja) 1985-08-10
EP0146863A3 (de) 1986-10-08
IL73879A0 (en) 1985-03-31
US4601895A (en) 1986-07-22
AU3658984A (en) 1985-06-27
HU191738B (en) 1987-04-28
DE3346571A1 (de) 1985-07-04
EP0146863A2 (de) 1985-07-03
KR850004393A (ko) 1985-07-15
HUT36704A (en) 1985-10-28
ES538675A0 (es) 1986-04-01
PT79701A (en) 1985-01-01
ZA8410045B (en) 1985-08-28
ES8605676A1 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
GB2132889B (en) Oral compositions
GB2166350B (en) Oral compositions
PH20978A (en) Oral preparation
GB8317561D0 (en) Oral composition
GB2151923B (en) Oral composition
GB2118184B (en) Phenoxyalkylcarboxylic acid derivatives
GR82580B (en) Retarding oral acetylsalicyl acid formulations
GB8514601D0 (en) Oral compositions
PT76871A (en) Oxazileacetic acid derivatives
GB2123817B (en) 4-hydroxy-3-quinoline-carboxylic acid derivatives
GB8402364D0 (en) Oral composition
GB8408978D0 (en) Oral compositions
DE3371070D1 (en) 4-amino-tetrahydro-2-naphthoic acid derivatives
GB8323624D0 (en) Medicinal compositions
DE3466477D1 (en) Pharmaceutical formulations
GB8301926D0 (en) N-methanesulfonic acid derivatives
GB8328717D0 (en) Oral compositions
GB2124214B (en) Apovincaminic acid derivatives
GB2121408B (en) Tetrazolylalkanohydroxamic acid derivatives
GB8318571D0 (en) Oral formulation
ZA832439B (en) Oral compositions
IE832541L (en) Oral compositions
ZA832438B (en) Oral compositions
IE832425L (en) Oral dosage form
GB8423571D0 (en) Oral formulation